We demonstrated previously that TLR1/2 activation (Pam3CSK4 treatment) in MM cells displayed heterogenous effects on the expression of adhesion molecules (αVβ3, α4, β7 integrins) and adhesion of these cells to BMSCs and FN [13, 20]. This evidence concerns the gene FN1 and Miyoshi myopathy.